Update on the ARCHES Trial: New Indication for Enzalutamide in mHSPC Grand Rounds in Urology 6:02 5 years ago 278 Далее Скачать
Enzalutamide + ADT in Men with De Novo mHSPC: The ARCHES Trial Grand Rounds in Urology 5:11 3 years ago 850 Далее Скачать
Update on ARCHES trial: implications for prostate cancer treatment VJOncology 3:57 5 years ago 369 Далее Скачать
ARCHES: OS by high or low disease volume and progression to mHSPC or de novo mHSPC VJOncology 1:35 2 years ago 253 Далее Скачать
ARCHES trial: androgen deprivation therapy with enzalutamide or placebo in mHSPC ecancer 3:43 5 years ago 310 Далее Скачать
ARCHES trial overview: ADT plus enzalutamide for metastatic hormone-sensitive prostate cancer VJOncology 1:55 5 years ago 446 Далее Скачать
Updated overall survival outcomes in ENZAMET (ANZUP 1304) European Association of Urology 6:40 2 years ago 542 Далее Скачать
ARCHES: OS in mHSPC who recieved prior ADT and reached low PSA further treated with enzalutamide VJOncology 1:37 2 years ago 61 Далее Скачать
Enzalutamide (XTANDI) for Prostate Cancer: Benefits, Side Effects, and 2024 Safety Update Mr. Lightyear 6:10 4 months ago 603 Далее Скачать
ARCHES post-hoc analyses: efficacy of ENZA + ADT in mHSPC by pattern of metastatic spread VJOncology 3:03 4 years ago 38 Далее Скачать
ENZAMET & ARCHES Trials Provides Evidence of Enzalutamide as Life Prolonging Therapy in mHSPC Grand Rounds in Urology 6:26 5 years ago 1 125 Далее Скачать
Andrew Armstrong, MD, presents an overview of the ARCHES trial in mHSPC OBRoncology 2:07 5 years ago 66 Далее Скачать
Clinical trial of ENZAMET shows it promising as prostate cancer treatment Medical Dialogues 1:52 1 year ago 238 Далее Скачать
Andrew Armstrong, MD, shares updates on the ARCHES study investigating enzalutamide in mPC patients OBRoncology 1:04 4 years ago 24 Далее Скачать
